Work

Supplementary Fig. S2 from Phase II Trial of Nelipepimut-S Peptide Vaccine in Women with Ductal Carcinoma In Situ

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Fig. S2: Nelipepimut-S (NPS)-specific cytotoxic T lymphocyte (CTL) responses in patients receiving GM-CSF alone with corresponding HER2 changes
Language: English
Subfield: Immunology
Open Access status: gold
OpenAlex ID: W4376126530
Cites:
Cited by:
Related to: 10